METLSRSLSKSLGELLASNSNNHFSRRSGSTIDDHDEEALKWAALEKLPTFARLRTTIIHPHEDLVDVTKLGVDDRQKFIDSIFKVTEEDNEKFLKKFRNRIDRVRIKLPTVEVRFEKVTIEANCHIGKRALPTLPNAALNIAERGLRLLGFNFTKTTKVTILRDVSGIIKPSRMTLLLGPPSSGKTTLLLALAGKLDQSLKVTGRVTYNGHGLEEFVPQKTSAYISQNDVHVGVMTVQETLDFSARCQGVGTRYDLLSELVRREKDAGILPEPEVDLFMKSIAAGNVKSSLITDYTLRILGLDICKDTVVGDEMIRGISGGQKKRVTTGEMIVGPTKTLFMDEISTGLDSSTTYQIVKCLQEIVRFTDATVLMSLLQPAPETFELFDDIILLSEGQIVYQGPRDHVLTFFETCGFKCPDRKGTADFLQEVTSRKDQEQYWADSKKPYSYISVSEFSKRFRTFHVGANLEKDLSVPYDRFKSHPASLVFKKHSVPKSQLFKVCWDRELLLMKRNAFFYITKTVQIIIMALIASTVYLRTEMGTKNESDGAVYIGALMFSMIVNMFNGFAELALMIQRLPVFYKQRDLLFHPPWTFSLPTFLLGIPISIFESVVWVTITYYMIGFAPELSRFLKHLLVIFLTQQMAGGIFRFIAATCRSMILANTGGALVILLLFLLGGFIVPRGEIPKWWKWAYWVSPMAYTYDALTVNEMLAPRWINQPSSDNSTSLGLAVLEIFDIFTDPNWYWIGVGGILGFTVLFNILVTLALTFLNPLEKQQAVVSKENTEENRAENGSKSKSIDVKRGMVLPFTPLTMSFDNVNYYVDMPKEMKEQGVSKDKLQLLKEVTGVFRPGVLTALMGVSGAGKTTLMDVLAGRKTGGYIEGDIRISGFPKRQETFARISGYCEQNDIHSPQVTVKESLIYSAFLRLPKEVTKYEKMRFVDEVMELVELESLKDAVVGLPGITGLSTEQRKRLTIAVELVANPSIIFMDEPTSGLDARAAAIVMRTVRNTVDTGRTVVCTIHQPSIDIFEAFDELLLLKRGGQVIYAGPLGQNSHKIIEYFQAIHGVPKIKEKYNPATWMLEVSSMAAEAKLEIDFAEHYKTSSLYQQNKNLVKELSTPPQGASDLYFSTRFSQSLLGQFKSCLWKQWITYWRTPDYNLARFFFTLAAAVMLGSIFWKVGTKRENANDLTKVIGAMYAAVLFVGVNNSSSVQPLIAVERSVFYRERAAEMYSALPYALAQVVCEIPYVLIQTTYYTLIIYAMMCFEWTLAKFFWFYFVSFMSFLYFTYYGMMTVALTPNQQVAAVFAGAFYGLFNLFSGFVIPRPRIPKWWIWYYWICPVAWTVYGLIVSQYGDVEDTIKVPGMANDPTIKWYIENHYGYDADFMIPIATVLVGFTLFFAFMFAFGIRTLNFQQR

peptide	modifiedsequence	code	pepprot
SLGELLASNSNNHFSR	SLGELLASN(pS)NNHFSR	AT3G16340.1	S20
SGSTIDDHDEEALK	(pS)GSTIDDHDEEAL(K*)	AT3G16340.1	S28
TLFMDEISTGLDSSTTYQIVK	(pT)LF(oxM)DEI(pS)TGLDSSTT(pY)QIVK	AT3G16340.1	T339_S346_Y355

AT3G16340.1

Description:

pleiotropic drug resistance 1

Solute transport.primary active transport.ABC superfamily.ABC2 family.subfamily ABCG transporter

ABCtransporter-like,ATP-bindingdomain PF00005;ABC-2typetransporter PF01061;PlantPDRABCtransporterassociated PF08370;ABC-transporter,N-terminaldomain PF14510;ABCtransporterfamilyGdomain PF19055;